Document is current
Any future updates will be listed below
-
Authors
Wang, Zhe
Zou, Peilin
Chen, Zhenzhong
Hou, Jiahui
Son, You Lee
Yamashita, Daisuke
Kondo, Toru https://orcid.org/0000-0002-7755-2650
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (17ck0106236h0002)
MEXT | Japan Society for the Promotion of Science (20H03559)
- License Information
-
More Information
Article History
Received: 22 July 2024
Revised: 18 March 2025
Accepted: 28 March 2025
First Online: 12 April 2025
Competing interests
: The authors declare no competing interests.
: Five primary human glioma samples, including three GBMs, one anaplastic astrocytoma (AA), and one diffuse oligodendroglioma (DO), were collected from Ehime University Hospital. Informed consent was obtained from all patients according to the Research Ethics Committee guidelines (approval number: 1208009) and the specimens were used to prepare glioma lines, GICs (E3, E6, E16), AA, and DO. The glioma lines were used in compliance with the research guidelines of the Ehime University Graduate School of Medicine and the Institute for Genetic Medicine of Hokkaido University.
